Background Drugs are a major source of greenhouse gas (GHG) emissions from healthcare
systems. Pressurized metered‐dose inhalers (pMDIs) have raised concerns over their …

A modifiable contributor to healthcare-derived greenhouse gas (GHG) emissions is the use
of inhaled therapy for respiratory conditions. Physicians prescribing inhalers may not always …

Background The global warming potential of inhaled medication depends on the applied
inhaler. Pressurised metered dose inhalers (pMDI) contain green-house gases (GHG) and …

Objectives Metered-dose inhalers (MDIs) contain propellants which are potent greenhouse
gases. Many agencies propose a switch to alternative, low global warming potential (GWP) …

Objectives Dry powder inhalers (DPIs) and soft mist inhalers have a substantially lower
global warming potential than pressurized metered-dose inhalers (pMDIs). To help mitigate …

Background The carbon footprint of Canada's health sector is among the worst in the world,
responsible for 4· 6% of Canada's total greenhouse gas emissions. A quarter of emissions …

Objectives Dry powder inhalers (DPIs) and soft mist inhalers have a substantially lower
global warming potential than pressurised metered-dose inhalers (pMDIs). To help mitigate …

Abstract Background Metered dose inhalers (MDIs) contain greenhouse gases which have a
disproportionate effect on the carbon footprint of healthcare. There are more environmentally …

Background RESPIMAT® re-usable enables patients to re-use the inhaler and its availability
therefore reduces the number of inhalers and associated wastage. Objective The objective …

Background Inhaled therapies are key components of asthma and chronic obstructive
pulmonary disease (COPD) treatments. Although the use of pressurised metered-dose …